J Pildal

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi request reprint Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review
    Julie Pildal
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Clin Infect Dis 39:38-46. 2004
  2. ncbi request reprint Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes
    J Pildal
    Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Copenhagen, Denmark
    Diabet Med 20:491-4. 2003
  3. pmc Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study
    Julie Pildal
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 330:1049. 2005
  4. ncbi request reprint Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus
    A M Møller
    Steno Diabetes Center and Hagedorn Research Institute, Copenhagen, Denmark
    J Clin Endocrinol Metab 86:2181-6. 2001

Detail Information

Publications4

  1. ncbi request reprint Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review
    Julie Pildal
    The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
    Clin Infect Dis 39:38-46. 2004
    ..61 (95% CI, 0.50-0.73). Because high-quality trials failed to demonstrate a reduction in mortality, polyclonal immunoglobulin should not be used for treatment of sepsis except in randomized clinical trials...
  2. ncbi request reprint Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes
    J Pildal
    Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Copenhagen, Denmark
    Diabet Med 20:491-4. 2003
    ....
  3. pmc Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study
    Julie Pildal
    Nordic Cochrane Centre, H S Rigshospitalet, DK 2100 Copenhagen, Denmark
    BMJ 330:1049. 2005
    ....
  4. ncbi request reprint Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus
    A M Møller
    Steno Diabetes Center and Hagedorn Research Institute, Copenhagen, Denmark
    J Clin Endocrinol Metab 86:2181-6. 2001
    ..In conclusion, we found no evidence supporting the hypothesis that genetic variability in the minimal promoter of the GLUT2 is associated with type 2 diabetes or prediabetic phenotypes in the Danish population...